cell injury

    Cards (17)

    • The components of cellular event inflammation includes understanding of the influx of leukocytes that is neutrophils and monocytes to the site of injury
    • Leukocyte migration from lumen to site of injury
      1. Margination
      2. Rolling
      3. Adhesion
      4. Transmigration
      5. Chemotaxis
    • Margination
      Redistribution of leukocytes along the margins of the blood vessels
    • Rolling
      Transient binding and detachment of leukocytes to endothelial cells
    • Selectins
      • Family of proteins that mediate the rolling phenomenon
      • P-selectin and E-selectin are expressed on activated endothelial cells
      • L-selectin is expressed on leukocytes
    • Adhesion
      Firm binding of leukocytes to endothelial cells mediated by integrins
    • Integrins
      • Transmembrane glycoproteins involved in adhesion
      • Expressed on activated leukocytes
      • Bind to ligands on endothelial cells
    • Transmigration
      Passage of leukocytes through the endothelial cell layer
    • PECAM-1
      • Cellular adhesion molecule that mediates transmigration
      • Also known as CD31
    • Chemotaxis
      Migration of leukocytes towards a chemotactic gradient
    • Chemotactic factors
      • Exogenous (bacterial products)
      • Endogenous (cytokines, complement factors, arachidonic acid metabolites)
    • Neutrophils predominate in the initial stages of acute inflammation, followed by monocytes after 24-48 hours
    • Neutrophils are more numerous, respond more rapidly to chemokines, and adhere more firmly to adhesion molecules compared to other leukocytes
    • Neutrophils are short-lived and undergo apoptosis, while monocytes survive longer and proliferate in tissues to become macrophages
    • There are exceptions, such as Pseudomonas infection where neutrophils continue to be recruited for several days, and viral infections where lymphocytes predominate
    • Understanding the mechanism of leukocyte recruitment provides potential therapeutic targets for controlling harmful inflammation
    • Examples of therapeutic targets include TNF blockers and integrin antagonists
    See similar decks